Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity

Food and Chemical Toxicology

Volumn 43, Issue 6, 2005, Pages 969-979

  He, Quanren ^a   Riley, Ronald T ^b   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Cytokine expression; Fumonisin; Hepatotoxicity; Myriocin; Sphinganine; Sphingolipids

Indexed keywords

FUMONISIN B1; SPHINGANINE; THERMOZYMOCIDIN;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; LIVER TOXICITY; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

FUSARIUM; GIBBERELLA MONILIFORMIS; SPHINGIODEA; ZEA MAYS;

EID: 16244393093     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.01.021     Document Type: Article

References (50)

1. H.U. Bergmeyer, M. Hørder, and R. Rej International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (l-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1) Journal of Clinical Chemistry and Clinical Biochemistry 24 1986 497 510
2. H.U. Bergmeyer, M. Hørder, and R. Rej International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (l-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2) Journal of Clinical Chemistry and Clinical Biochemistry 24 1986 481 495
3. 1-induced tumor necrosis factor α and interferon γ in mice Comparative Biochemistry and Physiology-Part C: Toxicology and Pharmacology 131 2002 113 122
4. 1 hepatotoxicity in BALB/c mice Toxicology 165 2001 195 204
5. 1 Chemico-Biological Interactions 139 2002 317 331
6. 1 toxicity Journal of Pharmacology and Experimental Therapeutics 285 1998 317 324
7. E.N. Enongene, R.P. Sharma, N. Bhandari, J.D. Miller, F.I. Meredith, K.A. Voss, and R.T. Riley Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase Toxicological Sciences 67 2002 173 181
8. T. Fujita, R. Hirose, M. Yoneta, S. Sasaki, K. Inoue, M. Kiuchi, S. Hirase, K. Chiba, H. Sakamoto, and M. Arita Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols Journal of Medicinal Chemistry 39 1996 4451 4459
9. W.C. Gelderblom, K. Jaskiewicz, W.F. Marasas, P.G. Thiel, R.M. Horak, R. Vleggaar, and N.P. Kriek Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme Applied and Environmental Microbiology 54 1988 1806 1811
10. 1, in rats Carcinogenesis 12 1991 1247 1251
11. Y.A. Hannun, C. Luberto, and K.M. Argraves Enzymes of sphingolipid metabolism: from modular to integrative signaling Biochemistry 40 2001 4893 4903
12. W.M. Haschek, L.A. Gumprecht, G. Smith, M.E. Tumbleson, and P.D. Constable Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives Environmental Health Perspectives 109 Supplement 2 2001 251 257
13. Q. He, R.T. Riley, and R.P. Sharma Fumonisin-induced tumor necrosis factor α expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition Toxicology and Applied Pharmacology 174 2001 69 77
14. 1): a model for reducing fumonisin-induced nephrotoxicity in vivo Pharmacology and Toxicology 90 2002 268 277
15. X. He, F. Chen, M.M. McGovern, and E.H. Schuchman A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism Analytical Biochemistry 306 2002 115 123
16. Q. He, V.J. Johnson, M.F. Osuchowski, and R.P. Sharma Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver Mycopathologia 157 2004 339 347
17. Q. He, J. Kim, and R.P. Sharma Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases Toxicological Sciences 80 2004 335 342
18. K.I.P.J. Hidari, S. Ichikawa, T. Fujita, H. Sakiyama, and Y. Hirabayashi Complete removal of sphingolipids from the plasma membrane disrupts cell to substratum adhesion of mouse melanoma cells Journal of Biological Chemistry 271 1996 14636 14641
19. 1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice Environmental Health Perspectives 109 Supplement 2 2001 277 282
20. Y. Jin, E. Knudsen, L. Wang, Y. Bryceson, B. Damaj, S. Gessani, and A.A. Maghazachi Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation Blood 101 2003 4909 4915
21. H. Le Stunff, I. Galve-Roperh, C. Peterson, S. Milstien, and S. Spiegel Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis Journal of Cell Biology 158 2002 1039 1049
22. 1, a carcinogenic mycotoxin produced by Fusarium moniliforme Carcinogenesis 20 1999 817 824
23. M. Maceyka, S.G. Payne, S. Milstien, and S. Spiegel Sphingosine kinase, sphingosine-1-phosphate, and apoptosis Biochimica et Biophysica Acta 1585 2002 193 201
24. W.F. Marasas Discovery and occurrence of the fumonisins: a historical perspective Environmental Health Perspectives 109 Suppl 2 2001 239 243
25. A.H. Merrill Jr., M.C. Sullards, E. Wang, K.A. Voss, and R.T. Riley Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins Environmental Health Perspectives 109 Supplement 2 2001 283 289
26. Y. Miyake, Y. Kozutsumi, S. Nakamura, T. Fujita, and T. Kawasaki Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin Biochemical and Biophysical Research Communications 211 1995 396 403
27. J. Ohanian, and V. Ohanian Sphingolipids in mammalian cell signalling Cellular and Molecular Life Sciences 58 2001 2053 2068
28. R.T. Riley, N.H. An, J.L. Showker, H.S. Yoo, W.P. Norred, W.J. Chamberlain, E. Wang, A.H. Merrill Jr., G. Motelin, and V.R. Beasley Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs Toxicology and Applied Pharmacology 118 1993 105 112
29. R.T. Riley, E. Wang, J.J. Schroeder, E.R. Smith, R.D. Plattner, H. Abbas, H.S. Yoo, A.H. Merrill, and Jr Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins Natural Toxins 4 1996 3 15
30. 3 Environmental Toxicology and Pharmacology 3 1997 221 228
31. R.T. Riley, K.A. Voss, W.P. Norred, C.W. Bacon, F.I. Meredith, and R.P. Sharma Serine palmitoyltransferase inhibition reverses anti-proliferative effects of ceramide synthase inhibition in cultured renal cells and suppresses free sphingoid base accumulation in kidney of BALB/c mice Environmental Toxicology and Pharmacology 7 1999 109 118
32. R.T. Riley, W.P. Norred, E. Wang, and A.H. Merrill Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices Natural Toxins 7 1999 407 414
33. R.T. Riley, E. Enongene, K.A. Voss, W.P. Norred, F.I. Meredith, R.P. Sharma, J. Spitsbergen, D.E. Williams, D.B. Carlson, and A.H. Merrill Jr. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis Environmental Health Perspectives 109 Supplement 2 2001 301 308
34. 1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases Toxicology and Applied Pharmacology 148 1998 252 260
35. 1 Journal of Comparative Pathology 117 1997 371 381
36. 1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor Cytokines 24 2003 226 236
37. E.R. Smith, and A.H. Merrill Jr. Differential roles of de novo sphingolipid biosynthesis and turnover in the burst of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture Journal of Biological Chemistry 270 1995 18749 18758
38. G.W. Smith, P.D. Constable, M.E. Tumbleson, G.E. Rottinghaus, and W.M. Haschek Sequence of cardiovascular changes leading to pulmonary edema in swine fed culture material containing fumonisin American Journal of Veterinary Research 60 1999 1292 1300
39. 1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion International Journal of Oncology 14 1999 833 843
40. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice Journal of Biochemical and Molecular Toxicology 12 1998 281 289
41. 3 cause hepato- and nephrotoxicity in rats Mycopathologia 141 1998 45 58
42. K.A. Voss, R.T. Riley, W.P. Norred, C.W. Bacon, F.I. Meredith, P.C. Howard, R.D. Plattner, T.F. Collins, D.K. Hansen, and J.K. Porter An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme Environmental Health Perspectives 109 Suppl 2 2001 259 266
43. E. Wang, W.P. Norred, C.W. Bacon, R.T. Riley, and A.H. Merrill Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme Journal of Biological Chemistry 266 1991 14486 14490
44. E. Wang, P.F. Ross, T.M. Wilson, R.T. Riley, and A.H. Merrill Jr. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme Journal of Nutrition 122 1992 1706 1716
45. 1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine Journal of Nutrition 129 1999 214 220
46. WHO (World Health Organization) (2000): Environmental Health Criteria 219. Fumonisin B1. In: Marasas, W.F.O., Miller, J.D., Riley, R.T., Visconti, A., International Programme on Chemical Safety, United Nations Environmental Programme, the International Labour Organization and the World Health Organization. World Health Oragnization, Geneva, Switzerland. pp. 1-150
47. R.D. Williams, E. Wang, and A.H. Merrill Enzymology of long-chain base synthesis by liver-characterization of serine palmitoyltransferase in rat-liver microsomes Archives of Biochemistry and Biophysics 228 1984 282 291
48. H.S. Yoo, W.P. Norred, J. Showker, and R.T. Riley Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity Toxicology and Applied Pharmacology 138 1996 211 218
49. T. Yoshizawa, A. Yamashita, and Y. Luo Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China Applied and Environmental Microbiology. 60 1994 1626 1629
50. 1 Food and Chemical Toxicology 39 2001 45 53